Period | Baseline (90 min) | After 60 min hypertonic saline infusion (150 min) | 90 min post hypertonic saline infusion (240 min) | P-value (difference in response) |
---|---|---|---|---|
p-Na (mmol/L) | ||||
Placebo | 140 ± 2 | 144 ± 2* | 141 ± 2* | 0.073 |
Furosemide | 139 ± 2 | 144 ± 2* | 141 ± 2* | |
p-K (mmol/L) | ||||
Placebo | 3.8 ± 0.2 | 3.7 ± 0.2* | 4.0 ± 0.2* | 0.001 |
Furosemide | 3.7 ± 0.2 | 3.5 ± 0.2*, † | 3.8 ± 0.2† | |
p-Cl(mmol/L) | ||||
Placebo | 105 ± 2 | 111 ± 2* | 107 ± 2* | < 0.001 |
Furosemide | 104 ± 2 | 108 ± 2*, † | 104 ± 2*, † | |
p-Osmolality (mmol/L) | ||||
Placebo | 282 ± 4 | 289 ± 3* | 286 ± 4* | 0.034 |
Furosemide | 282 ± 3 | 291 ± 3*, † | 286 ± 3* | |
p-total carbondioxide (mmol/L) | ||||
Placebo | 27 ± 2 | 25 ± 2* | 25 ± 2* | < 0.001 |
Furosemide | 26 ± 2 | 26 ± 2† | 27 ± 2† |